Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Tirzepatide-Placebo
DRUG
2 trials
Sponsors
Eli Lilly and Company
Conditions
Obesity
Overweight
Phase 1
A Study of LY3841136 in Japanese Participants With Obesity or Overweight
Completed
NCT06297616
Eli Lilly and Company
Obesity, Overweight
Start: 2024-04-15
End: 2025-11-21
Updated: 2026-01-16
Phase 2
A Study of Tirzepatide (LY3298176) Plus Mibavademab Compared With Tirzepatide Alone in Adult Participants With Obesity
Completed
NCT06373146
Eli Lilly and Company
Obesity
Start: 2024-04-24
End: 2026-04-02
Updated: 2026-05-06